Sr. Clinical Pharmacologist II
Gilead Sciences, Inc.
Chi-Chi Peng is a Senior Clinical Pharmacologist II at Gilead. Prior to joining Gilead, Chi-Chi was Director of DMPK at Brii, where she was responsible for both DMPK and clinical pharmacology research and development of CNS and infectious assets focusing on small molecules. She also held several roles in DMPK at Theravance, Amgen, Biogen and Baxter. Chi-Chi graduated with a Ph.D in Chemistry (Dr. Jeff Jones lab) from Washington State University and did her postdoctoral work at the University of Washington. Overall, Chi-Chi has over 10 years of experience in ADME, DDI and PBPK modeling in multiple disease areas including CNS, inflammation, cardiovascular, virology and oncology.